Mustang Bio Inc.

12/09/2021 | Press release | Distributed by Public on 12/09/2021 07:37

Mustang Bio to Host Key Opinion Leader Webinar on MB-106, a Potential Treatment for B-Cell Non Hodgkin Lymphomas and Chronic Lymphocytic Leukemia